HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation

Nucleic Acids Research

Volumn 38, Issue 2, 2009, Pages 633-646

  Mercenne, Gaëlle ^a   Bernacchi, Serena ^a   Richer, Delphine ^a   Bec, Guillaume ^a   Henriet, Simon ^a   Paillart, Jean Christophe ^a   Marquet, Roland ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; RIBONUCLEASE; VIF PROTEIN; APOBEC3G PROTEIN, HUMAN; CYTIDINE DEAMINASE; MESSENGER RNA; VIF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING SITE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOOTPRINTING; PROTEIN MULTIMERIZATION; PROTEIN RNA BINDING; RNA PROCESSING; TRANSLATION REGULATION; VIRUS TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MUTATION; PROTEIN SYNTHESIS; SPECTROFLUOROMETRY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; BINDING SITES; CYTIDINE DEAMINASE; HUMANS; MUTATION; PROTEIN BIOSYNTHESIS; PROTEIN FOOTPRINTING; RNA, MESSENGER; SPECTROMETRY, FLUORESCENCE; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77449117980     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp1009     Document Type: Article

References (38)

1. Sheehy,A.M., Gaddis,N.C., Choi,J.D. and Malim,M.H. (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature, 418, 646-650.
2. Wiegand,H.L., Doehle,B.P., Bogerd,H.P. and Cullen,B.R. (2004) A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J., 23, 2451-2458
3. Chiu,Y.L. and Greene,W.C. (2008) The APOBEC3 Cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol., 26, 317-353.
4. Henriet,S., Mercenne,G., Bernacchi,S., Paillart,J.C. and Marquet,R. (2009) Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors. Microbiol. Mol. Biol. Rev., 73, 211-232.
5. Holmes,R.K., Malim,M.H. and Bishop,K.N. (2007) APOBEC-mediated viral restriction: not simply editing? Trends Biochem. Sci., 32, 118-128.
6. Jarmuz,A., Chester,A., Bayliss,J., Gisbourne,J., Dunham,I., Scott,J. and Navaratnam,N. (2002) An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics, 79, 285-296.
7. Mariani,R., Chen,D., Schrofelbauer,B., Navarro,F., Konig,R., Bollman,B., Munk,C., Nymark-McMahon,H. and Landau,N.R. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell, 114, 21-31.
8. Marin,M., Rose,K.M., Kozak,S.L. and Kabat,D. (2003) HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med., 9, 1398-1403.
9. Sheehy,A.M., Gaddis,N.C. and Malim,M.H. (2003) The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med., 9, 1404-1407.
10. Stopak,K., de Noronha,C., Yonemoto,W. and Greene,W.C. (2003) HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell, 12, 591-601.
11. Yu,X., Yu,Y., Liu,B., Luo,K., Kong,W., Mao,P. and Yu,X.F. (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science, 302, 1056-1060.
12. Zheng,Y.H., Irwin,D., Kurosu,T., Tokunaga,K., Sata,T. and Peterlin,B.M. (2004) Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol., 78, 6073-6076.
13. Kao,S., Khan,M.A., Miyagi,E., Plishka,R., Buckler-White,A. and Strebel,K. (2003) The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity. J. Virol., 77, 11398-11407.
14. Li,J., Potash,M.J. and Volsky,D.J. (2004) Functional domains of APOBEC3G required for antiviral activity. J. Cell Biochem., 92, 560-572.
15. Liu,B., Yu,X., Luo,K., Yu,Y. and Yu,X.F. (2004) Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G. J. Virol., 78, 2072-2081.
16. Mehle,A., Strack,B., Ancuta,P., Zhang,C., McPike,M. and Gabuzda,D. (2004) Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitinproteasome pathway. J. Biol. Chem., 279, 7792-7798.
17. Conticello,S.G., Harris,R.S. and Neuberger,M.S. (2003) The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol., 13, 2009-2013
18. Liu,B., Sarkis,P.T., Luo,K., Yu,Y. and Yu,X.F. (2005) Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase. J. Virol., 79, 9579-9587.
19. Opi,S., Kao,S., Goila-Gaur,R., Khan,M.A., Miyagi,E., Takeuchi,H. and Strebel,K. (2007) Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant. J. Virol., 81, 8236-8246
20. Bernacchi,S., Henriet,S., Dumas,P., Paillart,J.C. and Marquet,R. (2007) RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study. J. Biol. Chem., 282, 26361-26368.
21. Henriet,S., Richer,D., Bernacchi,S., Decroly,E., Vigne,R., Ehresmann,B., Ehresmann,C., Paillart,J.C. and Marquet,R. (2005) Cooperative and specific binding of Vif to the 5′ region of HIV-1 genomic RNA. J. Mol. Biol., 354, 55-72.
22. Henriet,S., Sinck,L., Bec,G., Gorelick,R.J., Marquet,R. and Paillart,J.C. (2007) Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription. Nucleic Acids Res., 35, 5141-5153.
23. Zhang,H., Pomerantz,R.J., Dornadula,G. and Sun,Y. (2000) Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process. J. Virol., 74, 8252-8261.
24. Chatterjee,S. and Pal,J.K. (2009) Role of 5′and 3′-untranslated regions of mRNAs in human diseases. Biol. Cell, 101, 251-262
25. Wilkie,G.S., Dickson,K.S. and Gray,N.K. (2003) Regulation of mRNA translation by 5′and 3′-UTR-binding factors. Trends Biochem. Sci., 28, 182-188.
26. Muckenfuss,H., Kaiser,J.K., Krebil,E., Battenberg,M., Schwer,C., Cichutek,K., Munk,C. and Flory,E. (2007) Sp1 and Sp3 regulate basal transcription of the human APOBEC3G gene. Nucleic Acids Res., 35, 3784-3796.
27. Skripkin,E., Isel,C., Marquet,R., Ehresmann,B. and Ehresmann,C. (1996) Psoralen crosslinking between human immunodeficiency virus type 1 RNA and primer tRNA3(Lys). Nucleic Acids Res., 24, 509-514.
28. Yang,X., Goncalves,J. and Gabuzda,D. (1996) Phosphorylation of Vif and its role in HIV-1 replication. J. Biol. Chem., 271, 10121-10129.
29. McGhee,J.D. and von Hippel,P.H. (1974) Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice. J. Mol. Biol., 86, 469-489.
30. Tsodikov,O.V., Holbrook,J.A., Shkel,I.A. and Record,M.T., Jr. (2001) Analytic binding isotherms describing competitive interactions of a protein ligand with specific and nonspecific sites on the same DNA oligomer. Biophys. J., 81, 1960-1969.
31. Mely,Y., de Rocquigny,H., Sorinas-Jimeno,M., Keith,G., Roques,B.P., Marquet,R. and Gerard,D. (1995) Binding of the HIV-1 nucleocapsid protein to the primer tRNA(3Lys), in vitro,is essentially not specific. J. Biol. Chem., 270, 1650-1656
32. Woodbury,C.P., Jr. and von Hippel,P.H. (1983) On the determination of deoxyribonucleic acid-protein interaction parameters using the nitrocellulose filter-binding assay. Biochemistry, 22, 4730-4737.
33. Miller,J.H., Presnyak,V. and Smith,H.C. (2007) The dimerization domain of HIV-1 viral infectivity factor Vif is required to block APOBEC3G incorporation with virions. Retrovirology, 4, 81-92.
34. Yang,B., Gao,L., Li,L., Lu,Z., Fan,X., Patel,C.A., Pomerantz,R.J., DuBois,G.C. and Zhang,H. (2003) Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins. J. Biol. Chem., 278, 6596-6602.
35. Yang,S., Sun,Y. and Zhang,H. (2001) The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle. J. Biol. Chem., 276, 4889-4893
36. Barraud,P., Paillart,J.C., Marquet,R. and Tisne,C. (2008) Advances in the structural understanding of Vif proteins. Curr. HIV Res., 6, 91-99.
37. Paillart,J.C., Skripkin,E., Ehresmann,B., Ehresmann,C. and Marquet,R. (2002) In vitro evidence for a long range pseudoknot in the 5′-untranslated and matrix coding regions of HIV-1 genomic RNA. J. Biol. Chem., 277, 5995-6004.
38. Kao,S., Akari,H., Khan,M.A., Dettenhofer,M., Yu,X.F. and Strebel,K. (2003) Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection. J. Virol., 77, 1131-1140.